Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0031974 | membrane-enclosed lumen | 2 | 1 |
GO:0031981 | nuclear lumen | 5 | 1 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
GO:0043233 | organelle lumen | 3 | 1 |
GO:0070013 | intracellular organelle lumen | 4 | 1 |
GO:0097014 | ciliary plasm | 5 | 1 |
GO:0099568 | cytoplasmic region | 3 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9B4A9
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 11 | 15 | PF00656 | 0.748 |
CLV_C14_Caspase3-7 | 238 | 242 | PF00656 | 0.592 |
CLV_NRD_NRD_1 | 254 | 256 | PF00675 | 0.658 |
CLV_NRD_NRD_1 | 81 | 83 | PF00675 | 0.358 |
CLV_NRD_NRD_1 | 85 | 87 | PF00675 | 0.329 |
CLV_PCSK_KEX2_1 | 256 | 258 | PF00082 | 0.619 |
CLV_PCSK_KEX2_1 | 81 | 83 | PF00082 | 0.358 |
CLV_PCSK_KEX2_1 | 85 | 87 | PF00082 | 0.329 |
CLV_PCSK_PC1ET2_1 | 256 | 258 | PF00082 | 0.619 |
CLV_PCSK_PC7_1 | 81 | 87 | PF00082 | 0.444 |
CLV_PCSK_SKI1_1 | 102 | 106 | PF00082 | 0.416 |
CLV_PCSK_SKI1_1 | 172 | 176 | PF00082 | 0.591 |
CLV_Separin_Metazoa | 211 | 215 | PF03568 | 0.619 |
DEG_APCC_KENBOX_2 | 34 | 38 | PF00400 | 0.541 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.498 |
DEG_SCF_FBW7_1 | 49 | 55 | PF00400 | 0.659 |
DEG_SPOP_SBC_1 | 6 | 10 | PF00917 | 0.686 |
DOC_CKS1_1 | 201 | 206 | PF01111 | 0.494 |
DOC_CKS1_1 | 49 | 54 | PF01111 | 0.647 |
DOC_CYCLIN_yCln2_LP_2 | 201 | 207 | PF00134 | 0.644 |
DOC_MAPK_gen_1 | 226 | 233 | PF00069 | 0.517 |
DOC_MAPK_gen_1 | 81 | 91 | PF00069 | 0.348 |
DOC_MAPK_MEF2A_6 | 82 | 91 | PF00069 | 0.444 |
DOC_PP2B_PxIxI_1 | 72 | 78 | PF00149 | 0.557 |
DOC_USP7_MATH_1 | 135 | 139 | PF00917 | 0.767 |
DOC_USP7_MATH_1 | 243 | 247 | PF00917 | 0.733 |
DOC_USP7_MATH_1 | 52 | 56 | PF00917 | 0.662 |
DOC_USP7_MATH_1 | 6 | 10 | PF00917 | 0.714 |
DOC_USP7_UBL2_3 | 228 | 232 | PF12436 | 0.594 |
DOC_WW_Pin1_4 | 200 | 205 | PF00397 | 0.491 |
DOC_WW_Pin1_4 | 27 | 32 | PF00397 | 0.746 |
DOC_WW_Pin1_4 | 48 | 53 | PF00397 | 0.637 |
LIG_14-3-3_CanoR_1 | 192 | 201 | PF00244 | 0.575 |
LIG_14-3-3_CanoR_1 | 85 | 90 | PF00244 | 0.441 |
LIG_BRCT_BRCA1_1 | 87 | 91 | PF00533 | 0.401 |
LIG_FHA_1 | 196 | 202 | PF00498 | 0.489 |
LIG_FHA_1 | 225 | 231 | PF00498 | 0.642 |
LIG_FHA_1 | 243 | 249 | PF00498 | 0.601 |
LIG_FHA_2 | 108 | 114 | PF00498 | 0.375 |
LIG_FHA_2 | 125 | 131 | PF00498 | 0.614 |
LIG_LIR_Gen_1 | 203 | 213 | PF02991 | 0.602 |
LIG_LIR_Gen_1 | 39 | 49 | PF02991 | 0.493 |
LIG_LIR_Nem_3 | 39 | 44 | PF02991 | 0.466 |
LIG_SH2_CRK | 84 | 88 | PF00017 | 0.444 |
LIG_SH2_STAT5 | 124 | 127 | PF00017 | 0.572 |
LIG_SH2_STAT5 | 43 | 46 | PF00017 | 0.512 |
LIG_TRAF2_1 | 141 | 144 | PF00917 | 0.719 |
LIG_TRAF2_1 | 182 | 185 | PF00917 | 0.547 |
LIG_WRC_WIRS_1 | 38 | 43 | PF05994 | 0.599 |
MOD_CK1_1 | 195 | 201 | PF00069 | 0.590 |
MOD_CK1_1 | 9 | 15 | PF00069 | 0.700 |
MOD_CK2_1 | 107 | 113 | PF00069 | 0.481 |
MOD_CK2_1 | 124 | 130 | PF00069 | 0.552 |
MOD_CK2_1 | 5 | 11 | PF00069 | 0.710 |
MOD_GlcNHglycan | 11 | 14 | PF01048 | 0.778 |
MOD_GlcNHglycan | 137 | 140 | PF01048 | 0.716 |
MOD_GlcNHglycan | 238 | 241 | PF01048 | 0.655 |
MOD_GlcNHglycan | 55 | 58 | PF01048 | 0.691 |
MOD_GlcNHglycan | 63 | 66 | PF01048 | 0.732 |
MOD_GSK3_1 | 1 | 8 | PF00069 | 0.706 |
MOD_GSK3_1 | 107 | 114 | PF00069 | 0.429 |
MOD_GSK3_1 | 192 | 199 | PF00069 | 0.630 |
MOD_GSK3_1 | 27 | 34 | PF00069 | 0.643 |
MOD_GSK3_1 | 48 | 55 | PF00069 | 0.583 |
MOD_N-GLC_1 | 1 | 6 | PF02516 | 0.624 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.628 |
MOD_NEK2_1 | 197 | 202 | PF00069 | 0.630 |
MOD_PKA_1 | 85 | 91 | PF00069 | 0.444 |
MOD_PKA_2 | 85 | 91 | PF00069 | 0.441 |
MOD_Plk_4 | 111 | 117 | PF00069 | 0.414 |
MOD_Plk_4 | 124 | 130 | PF00069 | 0.494 |
MOD_ProDKin_1 | 200 | 206 | PF00069 | 0.492 |
MOD_ProDKin_1 | 27 | 33 | PF00069 | 0.726 |
MOD_ProDKin_1 | 48 | 54 | PF00069 | 0.647 |
TRG_DiLeu_BaLyEn_6 | 189 | 194 | PF01217 | 0.577 |
TRG_ENDOCYTIC_2 | 43 | 46 | PF00928 | 0.416 |
TRG_ENDOCYTIC_2 | 84 | 87 | PF00928 | 0.344 |
TRG_ER_diArg_1 | 80 | 82 | PF00400 | 0.358 |
TRG_ER_diArg_1 | 84 | 86 | PF00400 | 0.329 |
TRG_Pf-PMV_PEXEL_1 | 126 | 130 | PF00026 | 0.590 |
TRG_Pf-PMV_PEXEL_1 | 192 | 196 | PF00026 | 0.577 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I5Q0 | Leptomonas seymouri | 62% | 100% |
A0A1X0NSQ5 | Trypanosomatidae | 35% | 100% |
A0A3Q8IH27 | Leishmania donovani | 89% | 99% |
A4HLY0 | Leishmania braziliensis | 78% | 100% |
A4I9A9 | Leishmania infantum | 89% | 99% |
C9ZJB7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 38% | 100% |
Q4Q3R7 | Leishmania major | 90% | 100% |
V5BF66 | Trypanosoma cruzi | 38% | 100% |